Quantcast

Latest Cantel Medical Corp. Stories

2014-09-29 08:31:36

- 4th QTR FY14 EPS INCLUDES $0.02 OF ACQUISITION AND OTHER CHARGES LITTLE FALLS, N.J., Sept. 29, 2014 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) reported net income of $10,705,000, or $0.26 per diluted share, on a 15% increase in sales to a record $131,377,000 for the fourth quarter ended July 31, 2014, inclusive of $0.02 for charges related to acquisition and CFO retirement costs. This compares with net income of $10,213,000, or $0.25 per diluted share, on sales of...

2014-09-22 08:28:42

LITTLE FALLS, N.J., Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its fourth quarter and fiscal 2014 ended July 31, 2014 on Monday, September 29 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET. Participating in the call will be Charles M. Diker, Chairman; Andrew A. Krakauer, President and CEO; Jorgen B. Hansen, Executive Vice President and COO; Craig A. Sheldon, Senior Vice President, CFO and...

2014-09-10 08:31:01

MINNEAPOLIS, Sept. 10, 2014 /PRNewswire/ -- The ENDOCUFF(TM) Endoscopic Overtube now provided by MEDIVATORS, a leading medical device company with over thirty years of experience in endoscopy technology, substantially improves adenoma and polyp detection during colonoscopies according to two separate industry studies. The ENDOCUFF device is a small disposable plastic over-tube with soft flexible projections. Placed over the tip of the endoscope, the device helps increase control and...

2014-07-01 08:30:26

Enhances Cantel's global leadership in automated endoscope reprocessing LITTLE FALLS, N.J., July 1, 2014 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMN), today announced that the company has successfully completed the acquisition of PuriCore International Limited., a wholly-owned subsidiary of PuriCore plc (LSE: PURI). The transaction further enhances Cantel Medical's global leadership of automated endoscope reprocessing and provides the company with additional resources and...

2014-06-23 16:25:08

MINNEAPOLIS, June 23, 2014 /PRNewswire/ -- Medivators Inc., a Cantel Medical company and a leading medical device manufacturer with over thirty years in endoscopy technology, announces the debut of the JET PREP(TM) Endoscopic Flushing Device, a novel irrigation and suction device that clears and removes debris and obstructions from the colon during a colonoscopy, resulting in improved visualization of the gastrointestinal tract and increased polyp detection. Colonoscopy is an...

2014-06-05 08:28:37

EPS OF $0.25 (VS. $0.22) INCLUDES $0.01 OF ACQUISITION RELATED CHARGES LITTLE FALLS, N.J., June 5, 2014 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) reported net income of $10,249,000 or $0.25 per diluted share, on a 14% increase in sales to a record $120,058,000 for the third quarter ended April 30, 2014. These results are inclusive of $0.01 of acquisition related charges, including contingent consideration fair value adjustments and professional fees associated with our...

2014-06-04 08:31:33

Acquisition of UK-based automated endoscope reprocessor manufacturer significantly expands Cantel Medical's international capabilities LITTLE FALLS, N.J., June 4, 2014 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN), today announced that it entered into a definitive stock purchase agreement to acquire PuriCore International Ltd. for a purchase price of $26.9 million in cash consideration. PuriCore International, a wholly-owned subsidiary of PuriCore plc (LSE: PURI), is a leading...

2014-05-30 08:25:30

LITTLE FALLS, N.J., May 30, 2014 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its third quarter ended April 30, 2014 on Thursday, June 5 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET. Participating in the call will be Charles M. Diker, Chairman; Andrew A. Krakauer, President and CEO; Jorgen B. Hansen, Executive Vice President and COO; Craig A. Sheldon, Senior Vice President, CFO and Treasurer; and Seth...

2014-05-28 12:37:51

LITTLE FALLS, N.J. and CLEVELAND, May 28, 2014 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMN) and OsteoSymbionics, a leading designer and manufacturer of innovative, patient-specific craniofacial implants, are pleased to announce FDA (U.S. Food and Drug Administration) 510(k) clearance of OsteoSymbionics' signature ClearShield(TM) product made from Polymethyl methacrylate (PMMA). ClearShield(TM) is the first Class II medical device cleared by the FDA utilizing REVOX(®...

2014-05-19 08:28:44

LITTLE FALLS, N.J., May 19, 2014 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Jefferies 2014 Global Healthcare Conference at the Grand Hyatt Hotel in New York, New York. The formal presentation is scheduled for Monday, June 2, 2014 at 9:30 AM Eastern Time, with a Q & A session immediately following the presentation. In addition, Mr. Krakauer, Jorgen B. Hansen, Executive Vice President &...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related